Argyle Capital Management Inc. Organon & Co. Transaction History

Argyle Capital Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$31.66 - $38.9 $2,564 - $3,150	-81 Reduced 1.07%	7,462 $252,000
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $10,840 - $14,012	-356 Reduced 4.51%	7,543 $263,000
Q4 2021 Jan 25, 2022	SELL	$28.67 - $37.13 $7,740 - $10,025	-270 Reduced 3.31%	7,899 $241,000
Q3 2021 Oct 25, 2021	SELL	$28.63 - $35.64 $3,721 - $4,633	-130 Reduced 1.57%	8,169 $268,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $236,106 - $315,362	8,299 New	8,299 $251,000

805

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.94B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Argyle Capital Management Inc. with notifications on news.